Skip to main content

Table 4 Numbers of participants and prevalence in the year 1 survey, by study type and country

From: Gaining and sustaining schistosomiasis control: study protocol and baseline data prior to different treatment strategies in five African countries

Age group

Variable

Study - country

Sm2 - Kenya

Sm2 - Tanzania

Sh2 – Mozambique

Sh2 – Niger

Sm1 - Côte d’Ivoire

Sm1 - Kenya

Sh1 - Niger

5–8 years

Number enrolled

4,725

12,359

7,463

13,553

4,812

1,609

6,667

Prevalence (%)

35.7

38.5

63.1

24.0

5.3

5.8

3.3

9–12 years

Number enrolled

11,541

14,620

7,317

14,249

7,410

4,614

6,682

Prevalence (%)

62.7

55.5

66.6

21.3

20.9

17.7

4.2

Adults (20–55 years)

Number enrolled

7,107

4,922

4,259

7,041

N/A

N/A

N/A

Prevalence (%)

44.7

28.1

44.8

11.3

N/A

N/A

N/A

Total

Number enrolled

23,373

31,901

19,039

34,843

12,222

6,223

13,349

  1. N/A not assessed, Sh1 sustaining control study in S. haematobium endemic villages, Sh2 gaining control study in S. haematobium endemic villages, Sm1 sustaining control study in S. mansoni endemic villages, Sm2 gaining control study in S. mansoni endemic villages
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us